Operatsion marja: argenx (ARGX)

argenx BVBA (ARGX) brendining ramzi va logotipi

Kirish uchun yuqori to'siqlar va patent himoyasi argenx SE (ARGX) uchun huquqiy monopoliya yaratadi. GURU.Markets platformasida operatsion marjaning ushbu qisqa sharhi bu effektni namoyish etadi, bunda 28.80 bazaviy qiymat sifatida qayd etilgan. Terapiyaga bo'lgan barqaror talab ortiqcha foydalarni kafolatlaydi, dori vositalarining muvaffaqiyatli bozorga chiqarilishi esa makroiqtisodiy omillardan butunlay mustaqil bo'lgan shiddatli moliyaviy o'sishni ta'minlaydi.

argenx N.V. (ARGX): Operatsion foyda bo'yicha sotuv rentabelligi 04.07.2022dan 19.11.2026gacha

argenx.com - tahliliy kesimlar va asosiy koʻrsatkichlar (ARGX)

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning dastlabki tahlili:argenx.com, ARGX
argenx SE brendining mahsuloti

argenx SE uchun operatsion foyda marjasi qarz yuklamasi va soliqlarning ta'sirini hisobga olmagan holda, kompaniyaning kam uchraydigan kasalliklar terapiyalarini monetizatsiya qilish qobiliyatining ko'rsatkichi bo'lib xizmat qiladi. Ushbu koeffitsient operatsion foydaning daromadga bo'linishi orqali hisoblanadi, bu esa investorlarga asosiy dori vositasining yuqori marjali bozor segmentlarida tez sur'atlar bilan kengayishi sharoitida ichki xarajatlarni boshqarish samaradorligini baholash imkonini beradi.

argenx SE raqobatchilari

Operatsion rentabellik biontech.de|ABIVAX (ABVX) - Operatsion faoliyat rentabelligi|Operatsion marja ADMA|Operatsion foyda koeffitsiyenti PTGX|Operatsion rentabellik Immunovant Corp IMVT|Operatsion marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Operatsion rentabellik|Operatsion faoliyat rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Sotuvning operatsion marjasi|Aurinia Pharmaceuticals Inc. (AUPH) - Operatsion marja|Sotuvning operatsion marjasi BCRX|Sotuvning operatsion rentabelligi Vera Therapeutics Inc VERA|Sotuvning operatsion marjasi DNTH (Dianthus Pharma)|Operatsion faoliyat rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Sotuvning operatsion marjasi|Tourmaline Bio (TRML) - Sotuvning operatsion rentabelligi|PGEN - Operatsion rentabellik|Operatsion foyda normasi PHAR (Pharming Group NV)|NKTR: Operatsion marja|Upstream Bio Corp - Operatsion foyda normasi|Operatsion rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Operatsion faoliyat rentabelligi|Operatsion marja GOSS|Sotuvning operatsion marjasi KalVista Pharmaceuticals, Inc. KALV|Operatsion rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Sotuvning operatsion rentabelligi|SVRA - Operatsion rentabellik|Rigel Pharmaceuticals - Operatsion foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Operatsion rentabellik|ATXS - Operatsion faoliyat rentabelligi|Operatsion rentabellik enGene Holdings Inc.|RAPT: Operatsion foyda normasi|Operatsion marja JBIO|Sotuvning operatsion marjasi aclaristx.com ACRS|Operatsion rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Sotuvning operatsion rentabelligi|Cabaletta Bio, Inc - Operatsion marja|Sotuvning operatsion rentabelligi Ventyx Biosciences|THTX (theratech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operatsion marja|Sotuvning operatsion rentabelligi Agenus Inc. AGEN|Sotuvning operatsion marjasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operatsion foyda normasi|Operatsion rentabellik atyrpharma.com ATYR|Operatsion marja Adagene Corp ADAG|IMA - Operatsion rentabellik|Operatsion foyda normasi STTK (Shattuck Labs)|EQ: Operatsion marja|Connect Biopharma (CNTB) - Operatsion marja|Operatsion rentabellik Immunic|Operatsion marja atarabio.com|Operatsion marja IFRX|Operatsion marja X4 Pharma (XFOR)|Operatsion marja ACET (adicetbio.com)|Operatsion marja Celularity Inc. CELU|INMB - Operatsion rentabellik|Operatsion foyda normasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi SAB Biotherapeutics Inc.|Sotuvning operatsion marjasi AKTX|Sotuvning operatsion marjasi enlivex.com (ENLV)|Operatsion rentabellik Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operatsion foyda bo'yicha marjinallik|Operatsion marja EDSA (Edesa Biotech Corp)|Operatsion faoliyat rentabelligi iBio (IBIO)|CARM - Operatsion rentabellik|XTL Biopharmaceuticals (XTLB) - Sotuvning operatsion marjasi|BOLT: Operatsion marja|Sotuvning operatsion marjasi HCW Biologics Inc.|Operatsion rentabellik Aptevo|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com